Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pathology

• Publication date

  2017-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.4832PMID 27770445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

  2016cited by this paper
• Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.

  2016cited by this paper
• Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis

  2016cited by this paper
• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cited by this paper
• Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

  2016cited by this paper
• Epigenetic Determinants of Cancer.

  2016cited by this paper
• Targeting natural killer cells in cancer immunotherapy

  2016cited by this paper
• Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?

  2016cited by this paper
• TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.

  2016cited by this paper
• Combining Epigenetic and Immunotherapy to Combat Cancer.

  2016cited by this paper
• Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming

  2016cited by this paper
• Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion

  2016cited by this paper
• MicroRNA-491 regulates the proliferation and apoptosis of CD8+ T cells

  2016cited by this paper
• Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses

  2016cited by this paper
• HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

  2016cited by this paper
• A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

  2016cited by this paper
• MYC regulates the antitumor immune response through CD47 and PD-L1

  2016cited by this paper
• Epigenetic Control of Interferon-Gamma Expression in CD8 T Cells

  2015cited by this paper
• Mesenchymal Stem/Stromal Cells Protect against Autoimmunity via CCL2-Dependent Recruitment of Myeloid-Derived Suppressor Cells

  2015cited by this paper
• MicroRNA regulation of lymphocyte tolerance and autoimmunity.

  2015cited by this paper
• T cell exclusion, immune privilege, and the tumor microenvironment

  2015cited by this paper
• MicroRNA-22 Impairs Anti-Tumor Ability of Dendritic Cells by Targeting p38

  2015cited by this paper
• Immune checkpoint blockade: a common denominator approach to cancer therapy.

  2015cited by this paper
• RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis.

  2015cited by this paper
• Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer

  2015cited by this paper
• MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer

  2015cited by this paper
• The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.

  2015cited by this paper
• MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1

  2015cited by this paper
• Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.

  2015cited by this paper
• Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity

  2015cited by this paper
• Function and information content of DNA methylation

  2015cited by this paper
• Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T cell responses during pulmonary viral infection

  2015cited by this paper
• Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.

  2015cited by this paper
• Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

  2015cited by this paper
• Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress

  2015cited by this paper
• HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

  2015cited by this paper
• Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages.

  2015cited by this paper
• DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells

  2015cited by this paper
• Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans

  2015cited by this paper
• Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents

  2015cited by this paper
• Immune Checkpoint Blockade in Cancer Therapy.

  2015cited by this paper
• Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

  2015cited by this paper
• Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy

  2015cited by this paper
• Δ9‐Tetrahydrocannabinol‐mediated epigenetic modifications elicit myeloid‐derived suppressor cell activation via STAT3/S100A8

  2015cited by this paper
• DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells

  2014cited by this paper
• Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes

  2014cited by this paper
• Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses

  2014cited by this paper
• Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.

  2014cited by this paper
• MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells

  2014cited by this paper
• TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

  2014cited by this paper
• Epigenetic drugs as immunomodulators for combination therapies in solid tumors.

  2014cited by this paper
• Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

  2014cited by this paper
• Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

  2014cited by this paper
• Epigenetic plasticity of Cd8a locus during CD8+ T-cell development and effector differentiation and reprogramming

  2014cited by this paper
• Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.

  2014cited by this paper
• Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression

  2014cited by this paper
• MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene

  2014cited by this paper
• HDAC inhibitors and immunotherapy; a double edged sword?

  2014cited by this paper
• MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins*

  2014cited by this paper
• Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

  2014cited by this paper
• The cellular and molecular origin of tumor-associated macrophages

  2014cited by this paper
• Cross‐talk among myeloid‐derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors

  2014cited by this paper
• New and emerging HDAC inhibitors for cancer treatment.

  2014cited by this paper
• Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers

  2014cited by this paper
• DNA demethylating agent 5‐azacytidine inhibits myeloid‐derived suppressor cells induced by tumor growth and cyclophosphamide treatment

  2014cited by this paper
• Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways.

  2014cited by this paper
• MAGED4 expression in glioma and upregulation in glioma cell lines with 5-aza-2'-deoxycytidine treatment.

  2014cited by this paper
• MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.

  2014cited by this paper
• Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth

  2014cited by this paper
• Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

  2014cited by this paper
• MicroRNA 21 (miR-21) and miR-181b Couple with NFI-A To Generate Myeloid-Derived Suppressor Cells and Promote Immunosuppression in Late Sepsis

  2014cited by this paper
• Development and maintenance of regulatory T cells.

  2013cited by this paper
• Alterations of immune response of non-small cell lung cancer with Azacytidine

  2013cited by this paper
• Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

  2013cited by this paper
• MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway

  2013cited by this paper
• Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

  2013cited by this paper
• Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma

  2013cited by this paper
• Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses

  2013cited by this paper
• Distinct MicroRNA Expression Profile and Targeted Biological Pathways in Functional Myeloid-derived Suppressor Cells Induced by Δ9-Tetrahydrocannabinol in Vivo

  2013cited by this paper
• Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T Cells

  2013cited by this paper
• Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility

  2013cited by this paper
• The cancer‑testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo.

  2013cited by this paper
• The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity

  2013cited by this paper
• TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor‐specific cytotoxic T lymphocytes

  2013cited by this paper
• Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host

  2013cited by this paper
• MicroRNA-17, 20a Regulates the Proangiogenic Function of Tumor-Associated Macrophages via Targeting Hypoxia-Inducible Factor 2α

  2013cited by this paper
• Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.

  2013cited by this paper
• Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B‐cell lymphoma

  2013cited by this paper
• Innate and adaptive immune cells in the tumor microenvironment

  2013cited by this paper
• Immune-suppressive properties of the tumor microenvironment

  2013cited by this paper
• Epigenetic regulation of macrophage polarization and function.

  2013cited by this paper
• Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.

  2013cited by this paper
• KLF4 Modulates Expression of IL-6 in Dendritic Cells via Both Promoter Activation and Epigenetic Modification*

  2013cited by this paper
• Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages.

  2013cited by this paper
• History of myeloid-derived suppressor cells

  2013cited by this paper
• Influence of tumour micro-environment heterogeneity on therapeutic response

  2013cited by this paper
• Exosomes in tumor microenvironment influence cancer progression and metastasis

  2013cited by this paper
• EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

  2012cited by this paper
• Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.

  2012cited by this paper
• Tumor associated regulatory dendritic cells.

  2012cited by this paper

• Simplified acid extraction and quantification of histones in human tumor cells.

  2025cites this paper
• PHF20L1: An Epigenetic Regulator in Cancer and Beyond

  2025cites this paper
• Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer

  2025cites this paper
• Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion

  2025cites this paper
• Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer.

  2024cites this paper
• Targeting of TAMs: can we be more clever than cancer cells?

  2024cites this paper
• Unravelling the impact of epigenetic mechanisms on offspring growth, production, reproduction and disease susceptibility

  2024cites this paper
• Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity

  2024cites this paper
• 非小细胞肺癌免疫耐药机制及应对策略的研究进展

  2023cites this paper
• Strategies to Synergize PD-1/PD-L1 Targeted Cancer Immunotherapies to Enhance Antitumor Responses in Ovarian Cancer.

  2023cites this paper
• Epigenetics and immune cells in medulloblastoma

  2023cites this paper
• Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design.

  2023cites this paper
• STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway

  2022cites this paper
• PD-L1 small-molecule modulators: a new hope in epigenetic-based multidrug cancer therapy?

  2022cites this paper
• The mechanisms on evasion of anti-tumor immune responses in gastric cancer

  2022cites this paper
• Epigenetics in advanced renal cell carcinoma: potential new targets.

  2022cites this paper
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

  2022cites this paper
• Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy

  2022cites this paper
• The Potential Role of Mitochondrial Acetaldehyde Dehydrogenase 2 in Urological Cancers From the Perspective of Ferroptosis and Cellular Senescence

  2022cites this paper
• Epigenetic programming of the immune responses in cancer

  2022cites this paper
• Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

  2021cites this paper
• Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications.

  2021cites this paper
• Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

  2021cites this paper
• The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma

  2021cites this paper
• Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential

  2021cites this paper
• A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma

  2021cites this paper
• Roles of phenotypic heterogeneity and microenvironment feedback in early tumor development.

  2021cites this paper
• The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments

  2021cites this paper
• The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment

  2021cites this paper
• STING Agonist Enhances the Efficacy of PD-L1 Monoclonal Antibody in Breast Cancer Immunotherapy by Activating the IFNβ Signaling Pathway

  2021cites this paper
• The oncolytic virus VT09X optimizes immune checkpoint therapy in low immunogenic melanoma.

  2021cites this paper
• EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines

  2020cites this paper
• Evolution of the DNA methylome from precancer to invasive lung adenocarcinoma

  2020cites this paper
• Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

  2020cites this paper
• Understanding Checkpoint Inhibitors in Cancer Therapy, Mechanisms of Action, Resistance and Future Challenges

  2020cites this paper
• Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer

  2020cites this paper
• The roles of curcumin in regulating the tumor immunosuppressive microenvironment

  2020cites this paper
• The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment

  2020cites this paper
• Connections between Metabolism and Epigenetic Modification in MDSCs

  2020cites this paper
• Histone modifications in diseases

  2020cites this paper
• TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials

  2020cites this paper
• Transcriptional, Epigenetic and Metabolic Programming of Tumor-Associated Macrophages

  2020cites this paper
• Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?

  2019influential citation
• Myeloid-Derived Suppressor Cells in Sepsis

  2019cites this paper
• Epigenetics and Common Non Communicable Disease.

  2019cites this paper
• Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements

  2019cites this paper
• Dendritic Cells and Cancer: From Biology to Therapeutic Intervention

  2019cites this paper
• Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?

  2019cites this paper
• Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet

  2019cites this paper
• Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses

  2019cites this paper
• Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors

  2018influential citation
• Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.

  2018cites this paper
• Epigenetics in renal cell cancer: mechanisms and clinical applications

  2018cites this paper
• CCRK is a novel signalling hub exploitable in cancer immunotherapy

  2018cites this paper
• Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease

  2018influential citation
• Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy

  2018cites this paper
• Genomic Applications for Pediatric Orbital Tumours

  2018cites this paper
• MicroRNA-27a-5p Regulation by Promoter Methylation and MYC Signaling in Prostate Carcinogenesis

  2017cites this paper
• The Allergy Solution: A Clinical Conversation with Leo Galland, MD, and Robert Rountree, MD

  2017cites this paper
• Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

  2017cites this paper
• Acetylation and deacetylation in cancer stem-like cells.

  2017cites this paper
• DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment

  2017cites this paper
• Acetylation and deacetylation in cancer stem-like cells

  2017cites this paper